Phase II study of antineoplastic agents in Japan.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004341:Drug Evaluation / Q000379:methods*; D005260:Female; D006801:Humans; D007564:Japan; D009369:Neoplasms / Q000188:drug therapy*; D012075:Remission, Spontaneous; D013223:Statistics as Topic; D013997:Time Factors
D000970:Antineoplastic Agents